Auxilium Pharmaceuticals Inc (NASDAQ:AUXL)

CAPS Rating: 3 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Recs

0
Player Avatar TrackMagicFormul (84.12) Submitted: 4/25/2013 6:13:54 PM : Outperform Start Price: $17.19 AUXL Score: -17.12

Investors should consider selling puts. You can achieve some very high annualized returns at strikes significantly below the current price. e.g.

Sept 13 $15 strike, at $1.60, has 17% discount and 26% annualized return.

Member Avatar TrackMagicFormul (84.12) Submitted: 6/4/2014 8:39:30 AM
Recs: 0

Sept 2013 low was about $17, expired profitably.

Featured Broker Partners


Advertisement